Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy

Amy C. Yang, Bobby G. Ng, Steven A. Moore, Jeffrey Rush, Charles J. Waechter, Kimiyo M. Raymond, Tobias Willer, Kevin P. Campbell, Hudson H. Freeze, Lakshmi Mehta

Research output: Contribution to journalArticlepeer-review

70 Scopus citations


Congenital disorders of glycosylation (CDG) are rare genetic defects mainly in the post-translational modification of proteins via attachment of carbohydrate chains. We describe an infant with the phenotype of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase. Muscle biopsy showed muscular dystrophy and reduced α-dystroglycan immunostaining with glycoepitope-specific antibodies in a pattern diagnostic of dystroglycanopathy. Carbohydrate deficient transferrin testing showed a pattern pointing to a CDG type I. Sanger sequencing of DPM1 (dolichol-P-mannose synthase subunit 1) revealed a novel Gly > Val change c.455G > T missense mutation resulting in p.Gly152Val) of unknown pathogenicity and deletion/duplication analysis revealed an intragenic deletion from exons 3 to 7 on the other allele. DPM1 activity in fibroblasts was reduced by 80%, while affinity for the substrate was not depressed, suggesting a decrease in the amount of active enzyme. Transfected cells expressing tagged versions of wild type and the p.Gly152Val mutant displayed reduced binding to DPM3, an essential, non-catalytic subunit of the DPM complex, suggesting a mechanism for pathogenicity. The present case is the first individual described with DPM1-CDG ( CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy.

Original languageEnglish
Pages (from-to)345-351
Number of pages7
JournalMolecular Genetics and Metabolism
Issue number3
StatePublished - Nov 2013

Bibliographical note

Funding Information:
Work done at the Sanford Children's Health Research Center was made possible by the NIH grant R01DK55615 and The Rocket Fund . Work done at the University of Kentucky College of Medicine was supported by the NIH grant GM102129 . K.P.C. is an investigator of the Howard Hughes Medical Institute. The work done at the University of Iowa was also supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant ( U54NS053672 ).


  • CDG-Ie
  • Congenital disorder of glycosylation
  • Congenital muscular dystrophy
  • DPM1
  • DPM1-CDG
  • Dystroglycanopathy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology


Dive into the research topics of 'Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy'. Together they form a unique fingerprint.

Cite this